Skip to main content
. 2011 Aug 11;6(8):e22309. doi: 10.1371/journal.pone.0022309

Figure 1. Scenario A: Minimising health service costs and HCV health utility losses.

Figure 1

Simulations are with a 30% baseline prevalence, showing (A) programme coverage, (B) prevalence reductions, (C) number of treatments, (D) total health service costs (comprised of programme costs and infection costs), (E) infections averted, and (F) net monetary benefit. Parameters used are as shown in Tables 12, with Inline graphic, Inline graphic, Inline graphic, and with no final time prevalence constraint.